Table 2.
cDNA microarray analysis of KKLS cells treated with VEGF‐D
| Gene function | Gene symbol | Gene name | Fold change* |
|---|---|---|---|
| Cell cycle regulator | CCND1 | Cyclin D1 | 3 |
| CDK4 | Cyclin‐dependent kinase 4 | 2.8 | |
| Apoptosis | BCL2 | B‐cell CLL/lymphoma 2 | 6.3 |
| DAPK2 | Death‐associated protein kinase 1 | 5.9 | |
| NDUFA13 | Cell death‐regulatory protein GRIM19 | 2.8 | |
| Angiogenesis | THBS1 | Thrombospondin 1 | 7.3 |
| ANG | Angiogenin, ribonuclease, RNase A family, 5 | 4.2 | |
| Cell adhesion | CDH1 | Cadherin 1, type 1, E‐cadherin (epithelial) | 5.1 |
| ITGA7 | Integrin, alpha 7 | 3.8 | |
| CTNNA2 | Catenin (cadherin‐associated protein), alpha 2 | 3.6 | |
| VIM | Vimentin | 3.3 | |
| Motility, invasion | PLG | Plasminogen | 10.8 |
| PLAUR | Plasminogen activator, urokinase receptor | 4 | |
| AMFR | Autocrine motility factor receptor | 2.9 |
*Fold change = the degree of upregulation in comparison to expression in control (untreated) cells.